SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans.
Xuemei LiuTaolang LiZhiyuan MaBrigitte RiedererDumin YuanJiaxing ZhuYunhua LiJiaxing AnGuorong WenHai JinXiao YangUrsula SeidlerBiguang TuoPublished in: Cellular oncology (Dordrecht) (2022)
Our data indicate that SLC26A9 deletion in parietal cells is sufficient to trigger gastric metaplasia and the development of neoplastic lesions. In addition, we found that SLC26A9 expression decreases during human gastric carcinogenesis, and that exogenous SLC26A9 expression in GC cells reduces their malignant behavior.